This report contains market size and forecasts of Interleukin 17A in global, including the following market information:
Global Interleukin 17A Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Interleukin 17A Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Interleukin 17A companies in 2020 (%)
The global Interleukin 17A market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interleukin 17A manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interleukin 17A Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Interleukin 17A Market Segment Percentages, By Type, 2020 (%)
ABY-035
CNTO-6785
DLX-2882
Others
Global Interleukin 17A Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Interleukin 17A Market Segment Percentages, By Application, 2020 (%)
Chronic Pain
Liver Cancer
Kidney Cancer
Others
Global Interleukin 17A Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Interleukin 17A Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Interleukin 17A revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Interleukin 17A revenues share in global market, 2020 (%)
Key companies Interleukin 17A sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Interleukin 17A sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis AG
Orega Biotech SAS
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Interleukin 17A Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Interleukin 17A Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Interleukin 17A Overall Market Size
2.1 Global Interleukin 17A Market Size: 2021 VS 2027
2.2 Global Interleukin 17A Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Interleukin 17A Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Interleukin 17A Players in Global Market
3.2 Top Global Interleukin 17A Companies Ranked by Revenue
3.3 Global Interleukin 17A Revenue by Companies
3.4 Global Interleukin 17A Sales by Companies
3.5 Global Interleukin 17A Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Interleukin 17A Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Interleukin 17A Product Type
3.8 Tier 1, Tier 2 and Tier 3 Interleukin 17A Players in Global Market
3.8.1 List of Global Tier 1 Interleukin 17A Companies
3.8.2 List of Global Tier 2 and Tier 3 Interleukin 17A Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Interleukin 17A Market Size Markets, 2021 & 2027
4.1.2 ABY-035
4.1.3 CNTO-6785
4.1.4 DLX-2882
4.1.5 Others
4.2 By Type - Global Interleukin 17A Revenue & Forecasts
4.2.1 By Type - Global Interleukin 17A Revenue, 2016-2021
4.2.2 By Type - Global Interleukin 17A Revenue, 2022-2027
4.2.3 By Type - Global Interleukin 17A Revenue Market Share, 2016-2027
4.3 By Type - Global Interleukin 17A Sales & Forecasts
4.3.1 By Type - Global Interleukin 17A Sales, 2016-2021
4.3.2 By Type - Global Interleukin 17A Sales, 2022-2027
4.3.3 By Type - Global Interleukin 17A Sales Market Share, 2016-2027
4.4 By Type - Global Interleukin 17A Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Interleukin 17A Market Size, 2021 & 2027
5.1.2 Chronic Pain
5.1.3 Liver Cancer
5.1.4 Kidney Cancer
5.1.5 Others
5.2 By Application - Global Interleukin 17A Revenue & Forecasts
5.2.1 By Application - Global Interleukin 17A Revenue, 2016-2021
5.2.2 By Application - Global Interleukin 17A Revenue, 2022-2027
5.2.3 By Application - Global Interleukin 17A Revenue Market Share, 2016-2027
5.3 By Application - Global Interleukin 17A Sales & Forecasts
5.3.1 By Application - Global Interleukin 17A Sales, 2016-2021
5.3.2 By Application - Global Interleukin 17A Sales, 2022-2027
5.3.3 By Application - Global Interleukin 17A Sales Market Share, 2016-2027
5.4 By Application - Global Interleukin 17A Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Interleukin 17A Market Size, 2021 & 2027
6.2 By Region - Global Interleukin 17A Revenue & Forecasts
6.2.1 By Region - Global Interleukin 17A Revenue, 2016-2021
6.2.2 By Region - Global Interleukin 17A Revenue, 2022-2027
6.2.3 By Region - Global Interleukin 17A Revenue Market Share, 2016-2027
6.3 By Region - Global Interleukin 17A Sales & Forecasts
6.3.1 By Region - Global Interleukin 17A Sales, 2016-2021
6.3.2 By Region - Global Interleukin 17A Sales, 2022-2027
6.3.3 By Region - Global Interleukin 17A Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Interleukin 17A Revenue, 2016-2027
6.4.2 By Country - North America Interleukin 17A Sales, 2016-2027
6.4.3 US Interleukin 17A Market Size, 2016-2027
6.4.4 Canada Interleukin 17A Market Size, 2016-2027
6.4.5 Mexico Interleukin 17A Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Interleukin 17A Revenue, 2016-2027
6.5.2 By Country - Europe Interleukin 17A Sales, 2016-2027
6.5.3 Germany Interleukin 17A Market Size, 2016-2027
6.5.4 France Interleukin 17A Market Size, 2016-2027
6.5.5 U.K. Interleukin 17A Market Size, 2016-2027
6.5.6 Italy Interleukin 17A Market Size, 2016-2027
6.5.7 Russia Interleukin 17A Market Size, 2016-2027
6.5.8 Nordic Countries Interleukin 17A Market Size, 2016-2027
6.5.9 Benelux Interleukin 17A Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Interleukin 17A Revenue, 2016-2027
6.6.2 By Region - Asia Interleukin 17A Sales, 2016-2027
6.6.3 China Interleukin 17A Market Size, 2016-2027
6.6.4 Japan Interleukin 17A Market Size, 2016-2027
6.6.5 South Korea Interleukin 17A Market Size, 2016-2027
6.6.6 Southeast Asia Interleukin 17A Market Size, 2016-2027
6.6.7 India Interleukin 17A Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Interleukin 17A Revenue, 2016-2027
6.7.2 By Country - South America Interleukin 17A Sales, 2016-2027
6.7.3 Brazil Interleukin 17A Market Size, 2016-2027
6.7.4 Argentina Interleukin 17A Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Interleukin 17A Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Interleukin 17A Sales, 2016-2027
6.8.3 Turkey Interleukin 17A Market Size, 2016-2027
6.8.4 Israel Interleukin 17A Market Size, 2016-2027
6.8.5 Saudi Arabia Interleukin 17A Market Size, 2016-2027
6.8.6 UAE Interleukin 17A Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 AbbVie Inc
7.1.1 AbbVie Inc Corporate Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Interleukin 17A Major Product Offerings
7.1.4 AbbVie Inc Interleukin 17A Sales and Revenue in Global (2016-2021)
7.1.5 AbbVie Inc Key News
7.2 Abeome Corporation
7.2.1 Abeome Corporation Corporate Summary
7.2.2 Abeome Corporation Business Overview
7.2.3 Abeome Corporation Interleukin 17A Major Product Offerings
7.2.4 Abeome Corporation Interleukin 17A Sales and Revenue in Global (2016-2021)
7.2.5 Abeome Corporation Key News
7.3 Affibody AB
7.3.1 Affibody AB Corporate Summary
7.3.2 Affibody AB Business Overview
7.3.3 Affibody AB Interleukin 17A Major Product Offerings
7.3.4 Affibody AB Interleukin 17A Sales and Revenue in Global (2016-2021)
7.3.5 Affibody AB Key News
7.4 Cell Medica Limited
7.4.1 Cell Medica Limited Corporate Summary
7.4.2 Cell Medica Limited Business Overview
7.4.3 Cell Medica Limited Interleukin 17A Major Product Offerings
7.4.4 Cell Medica Limited Interleukin 17A Sales and Revenue in Global (2016-2021)
7.4.5 Cell Medica Limited Key News
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Corporate Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Interleukin 17A Major Product Offerings
7.5.4 Eli Lilly and Company Interleukin 17A Sales and Revenue in Global (2016-2021)
7.5.5 Eli Lilly and Company Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Interleukin 17A Major Product Offerings
7.6.4 Johnson & Johnson Interleukin 17A Sales and Revenue in Global (2016-2021)
7.6.5 Johnson & Johnson Key News
7.7 Merck KGaA
7.7.1 Merck KGaA Corporate Summary
7.7.2 Merck KGaA Business Overview
7.7.3 Merck KGaA Interleukin 17A Major Product Offerings
7.4.4 Merck KGaA Interleukin 17A Sales and Revenue in Global (2016-2021)
7.7.5 Merck KGaA Key News
7.8 Novartis AG
7.8.1 Novartis AG Corporate Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Interleukin 17A Major Product Offerings
7.8.4 Novartis AG Interleukin 17A Sales and Revenue in Global (2016-2021)
7.8.5 Novartis AG Key News
7.9 Orega Biotech SAS
7.9.1 Orega Biotech SAS Corporate Summary
7.9.2 Orega Biotech SAS Business Overview
7.9.3 Orega Biotech SAS Interleukin 17A Major Product Offerings
7.9.4 Orega Biotech SAS Interleukin 17A Sales and Revenue in Global (2016-2021)
7.9.5 Orega Biotech SAS Key News
8 Global Interleukin 17A Production Capacity, Analysis
8.1 Global Interleukin 17A Production Capacity, 2016-2027
8.2 Interleukin 17A Production Capacity of Key Manufacturers in Global Market
8.3 Global Interleukin 17A Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Interleukin 17A Supply Chain Analysis
10.1 Interleukin 17A Industry Value Chain
10.2 Interleukin 17A Upstream Market
10.3 Interleukin 17A Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Interleukin 17A Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Interleukin 17A in Global Market
Table 2. Top Interleukin 17A Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Interleukin 17A Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Interleukin 17A Revenue Share by Companies, 2016-2021
Table 5. Global Interleukin 17A Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Interleukin 17A Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Interleukin 17A Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Interleukin 17A Product Type
Table 9. List of Global Tier 1 Interleukin 17A Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Interleukin 17A Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
AbbVie Inc
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis AG
Orega Biotech SAS